Alzheimer; News from the web:
The results of the clinical studies submitted by the drug’s manufacturer, Biogen, and the FDA’s accelerated approval, have been highly criticized by experts in the field.

Read all about it HERE
Alzheimer; News from the web:
The results of the clinical studies submitted by the drug’s manufacturer, Biogen, and the FDA’s accelerated approval, have been highly criticized by experts in the field.

Read all about it HERE
Alzheimer; News from the web:
Stanford University researchers invite you to participate in Feasibility of At-Home Telehealth Yoga for Treating Chronic Pain. This research study aims to test whether it is feasible to use telehealth to deliver yoga as a treatment for chronic pain for people with Alzheimer’s disease.
Read all about it HERE
Alzheimer; News from the web:
A trio of new studies finds that air quality appears linked to a risk of thinking declines and dementia, and bad air might even promote toxic brain proteins that are a hallmark of Alzheimer’s disease.
Read all about it HERE
Alzheimer; News from the web:
The recent FDA approval of a new medicine for Alzheimer’s has still some questions about who is eligible to get it, the costs and more. Read the article in our link for today for some insights.
Read all about it HERE
Alzheimer; News from the web:
For years, the terms “Alzheimer’s” and “dementia” have been used interchangeably. But the difference between them is important, say experts at the Oklahoma Medical Research Foundation, with no better time to learn than June: Alzheimer’s and Brain Awareness Month.
Read all about it HERE
Alzheimer; News from the web:
A newly approved drug to treat Alzheimer’s disease is expected to become a multibillion-dollar expense for Medicare. By one projection, spending on the drug for Medicare’s patients could end up being higher than the budgets for the Environmental Protection Agency or NASA.
Read all about it HERE